**Executive Summary**
The Ministry of Chemicals and Fertilizers has announced a budgetary provision of ₹13,000 crore for Bio-Pharma SHAKTI and three dedicated Chemical Parks. This initiative is a strategic investment in India's future, aiming to increase its global chemical sector share to 5-6% by 2030 and achieve a $1 trillion turnover by 2040. The document, posted on March 3, 2026, outlines the rationale and components of this significant budgetary allocation.
**Key Points / Main Content**
**Bio-Pharma Mission and Investment**
* A budget of ₹10,000 crore is allocated for the BioPharma Mission over the next five years.
* This mission aims to address the global shift towards biologics, with 40% of medicines expected to be biologics by 2035.
* India aims to capture a 1% share of the global biosimilars market, projecting an annual opportunity of ₹2 lakh crore.
* Institutions like NIPER will be strengthened, and 1,000 clinical trial sites will be developed to enhance research and innovation.
* The Central Drugs Standard Control Organization (CDSCO) will be reinforced to expedite approvals for biosimilars and drug fermentation.
**Chemical Parks and Sector Growth**
* ₹3,300 crore is allocated for three dedicated world-class chemical parks.
* These parks will feature plug-and-play utilities, advanced effluent treatment systems, integrated logistics, and safety mechanisms.
* The parks are expected to reduce costs by 20-40% through industrial symbiosis and promote a circular economy.
* The overarching goal is to increase India's global chemical sector share to 5-6% by 2030 and achieve a $1 trillion turnover by 2040.
**Post-Budget Webinar and Collaboration**
* Post-Budget Webinars are exemplified as a "Whole of Government Approach."
* The webinars bring together policymakers, industry leaders, financial institutions, and domain experts to discuss growth strategies.
* Sustained economic growth requires active participation and shared responsibility from all stakeholders.
* Progress necessitates deeper collaboration across ministries, states, and industry.
**Impact Analysis**
**Chemical and Pharmaceutical Industry**
* **Impact:** The allocation provides significant financial impetus for growth in the biopharma and chemical sectors. It supports infrastructure development, research and development, and regulatory streamlining, aiming to boost India's global competitiveness and revenue.
* **Action Required:** Industry stakeholders should leverage the allocated funds and infrastructure development for expansion, innovation, and market penetration in biosimilars and chemicals.
**Government Ministries and Departments (e.g., Ministry of Chemicals and Fertilizers, CDSCO)**
* **Impact:** These bodies will be instrumental in implementing the BioPharma Mission and developing the chemical parks. They will oversee the allocation and utilization of funds, streamline regulatory processes, and foster collaboration.
* **Action Required:** Continued strategic planning, efficient fund management, and coordinated execution of policies to achieve the stated growth targets.
**Research Institutions (e.g., NIPER)**
* **Impact:** These institutions will receive strengthened support, enabling them to enhance talent and skill development and contribute to research and innovation in the biopharmaceutical sector.
* **Action Required:** Integrate closely with talent and skill development initiatives and focus on developing clinical trial sites to boost research capacity.
Key Entities Referenced
BioPharma SHAKTI: A scheme for the biopharmaceutical sector, involving a budgetary provision of Rs 13,000 crore.
J P Nadda: Union Minister of Chemicals and Fertilizers, who addressed the post-Budget Webinar and highlighted the strategic importance of the BioPharma SHAKTI and dedicated Chemical Parks.
Central Drugs Standard Control Organization (CDSCO): An organization that will be strengthened to support biosimilars and fermentation of drugs, playing a role in faster regulatory approvals.
Budget 2026-27: The budget announcements for which the post-budget webinar was held, with a focus on accelerating India's growth trajectory and ensuring effective implementation.
NIPER: An institution that needs to be strengthened by integrating more closely with talent and skill development to enhance research capacity and innovation.
Ministry of Chemicals and Fertilizers
Provision of Rs 13000 cr for BioPharma SHAKTI
& 3 Dedicated Chemical Parks is a strategic bet
on India’s future
India’s global chemical sector share to increase to 5–6% by
2030 and achieve a $1 trillion turnover by 2040.
Post Budget Webinars are an example for Whole of
Government Approach -Union Minister J P Nadda
Posted On: 03 MAR 2026 8:28PM by PIB Delhi
Budgetary Provision of ₹13,000 cr for Bio-Pharma SHAKTI and 3 dedicated Chemical Parks in the
country is a strategic bet on India’s future said Union Minister of Chemicals and Fertilisers Shri J P
Nadda. Addressing the post-Budget Webinar on the theme “Sustaining and Strengthening Economic
Growth” today he said that as emphasised by Prime Minister Shri Narendra Modi in his opening remarks
FTAs are a gateway for Viksit Bharat and new opportunities for Indian industries to expand
globally.
Noting that India became ‘Pharmacy of the world’ through generics, the Minister said 40% of medicines
globally will be biologics by 2035. $300 billion worth patents are expiring by 2030. Now is the time to
move towards Biologics and India is committed to face the challenge with the BioPharma Mission. A
budget of ₹10,000 crore has been allocated to be utilized over next five-years for this mission. A 1% share
in the global biosimilars market, could translate into an annual opportunity of ₹2 lakh crore for India, he
added.The Minister further said that it is essential to strengthen institutions like NIPER by integrating them more
closely with talent and skill development. Developing 1,000 clinical trial sites across the country will
enhance research capacity and innovation. Emphasising the role of Central Drugs Standard Control
Organization (CDSCO) for faster regulatory approvals, the Minister said the organisation will be
strengthened to support biosimilars and fermentation of drugs.
Shri Nadda highlighted that while India’s chemical sector’s output is worth ₹19.4 lakh crore and is strong
in segments like dyes and agrochemicals, its global share remains at 3%. Identifying infrastructure as the
key gap, the Minister said ₹3,300 crore for 3 dedicated world-class chemical parks across the country
with plug-and-play utilities, advanced effluent treatment systems, integrated logistics, and built-in safety
mechanisms would address that gap. These parks are expected to enable 20–40% cost reduction through
industrial symbiosis and promote a circular economy by design. Shri Nadda outlined an ambitious
vision to increase India’s global chemical sector share to 5–6% by 2030 and achieve a $1 trillion
turnover by 2040.
Highlighting the importance of collective ownership, Shri Nadda stated that sustained economic growth
requires active participation and shared responsibility among all stakeholders. He described the webinar
itself as a living example of this approach, showcasing coordinated efforts across sectors and institutions.
He stressed that progress cannot be achieved through isolated efforts and called for deeper collaboration
across ministries, states, and industry. He appreciated the deliberations through the day and described it as
a positive contribution towards realisation Budget 2026-27 announcements.
The post budget webinar was second in the series that brought together policymakers, industry leaders,
financial institutions, and domain experts to deliberate on strategies for accelerating India’s growth
trajectory and ensuring effective implementation of Budget 2026–27 announcements.
—--
PC/DKR/PM
(Release ID: 2235160) Visitor Counter : 329
Read this release in: Tamil